1Pedersen TR,Olsson AG,Faergeman O,et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease in the Scandinavian Simvastain Survival Study (4S).Circulation,1998,97(15):1453-1460.
2Flaker GC,Wamica JW,Sacks FM,et al. Pravastatin prevents clincal events in revascularized patients with average cholesterol concentrations:Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol, 1999,34(1): 106-112.
4Corti R,Fayed ZA,Fuster V,et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions:a longitudinal study by high-resolution, noninvasive nagnetic resonance imaging. Circulation, 2001,104(3):249-252.
5Crisby M,Shah PK,Yano J,et al.Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques:implications for plaque stabilization, Circulation, 2001,103(7):926-933.
8Ducobu J. Low dose (5 mg)simvastatin versus gemfibrozil in the treatment of primary moderate hypercholesterolemia: results of a multicenter study. Curr Therap Res, 1994,52:199-210.
4Hennerici M,Siegel NJ,Kappelman NB,et al.Detection of early arterosiclerotic lesinos by duplex scanning of the carotid artery[].Journal of Clinical Ultrasound.1984
5Ghaso A,Itacce C,Pujia PIM.Carotid in tima-media thickness and coronary heart risk facts[].Journal of Atherosclerosis Research.1996
6The Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S[].LancetThe.1994
